Self-sampling for HPV testing in cervical cancer screening: A scoping review
Cervical cancer is the fourth most common cancer affecting women worldwide, following breast, colorectal, and lung cancers, with 569,847 new cases reported every year [1]. The estimated incidence is 13.1 per 100,000 women, and there is an estimated mortality rate of 6.9 per 100,000 cases [2]. The primary cause of this type of cancer is intraepithelial lesions induced by high-risk Human Papillomavirus (HPV) types, which are detected in 99.7 % of cervical cancer cases [3]. Early diagnosis is one of the primary methods for preventing the progression of intraepithelial lesions that carry a risk of developing into cervical cancer.
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - Category: OBGYN Authors: Tamy Colonetti, Maria Laura R. Uggioni, Ana Luiza M. Dos Santos, N áiade M. Uggioni, Laura U. Elibio, Eduarda L. Balbinot, Antonio J. Grande, Maria Inês da Rosa Tags: Review article Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Cervical Cancer | Colorectal Cancer | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | OBGYN | Women